source
- Gilead reports positive Phase 2 results for oral ulcerative colitis drugGilead announced that its experimental oral therapy for ulcerative colitis achieved positive results in a Phase 2 trial. The study reported that patients receiving the drug showed measurable clini…
- Enlivex cuts 60% of staff, halts preclinical R&D and slashes exec salaries to fund osteoarthritis trialEnlivex, an Israeli biotech developing a cell‑based immunotherapy called allocetra for knee osteoarthritis, announced today that it is reducing its workforce by 60 percent. The cut reduces the sta…